December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

64.54 -0.66 (-1.01%)
Streaming Delayed Price Updated: 2:21 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 685,049
Open 65.20
Bid (Size) 64.52 (2)
Ask (Size) 64.55 (2)
Prev. Close 65.20
Today's Range 64.19 - 65.62
52wk Range 42.01 - 79.50
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Halozyme Therapeutics Inc (NASDAQ:HALO) Demonstrates Strong Growth and Profitability
Discover Halozyme Therapeutics, a top growth stock with strong earnings, soaring revenue, and high profitability. A prime example of the Navellier investing method. 
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO): A Prime Candidate for Affordable Growth
Halozyme Therapeutics (HALO) offers strong growth, high profitability, and an attractive valuation, making it a compelling GARP (Growth at a Reasonable Price) investment candidate. 
Via Chartmill

Performance

YTD
+34.4%
+34.4%
1 Month
-14.9%
-14.9%
3 Month
+14.1%
+14.1%
6 Month
+6.4%
+6.4%
1 Year
+19.2%
+19.2%

More News

Read More
Forecasting The Future: 7 Analyst Projections For Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a High-Growth Momentum and Technical Breakout Opportunity
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Embodies Navellier's Growth Investing Principles
Via Chartmill
Earnings Scheduled For August 5, 2025
Via Benzinga
Earnings Outlook For Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Case for Value Investors
Via Chartmill
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
Via Investor's Business Daily
Topics ETFs
Halozyme Therapeutics Inc (NASDAQ:HALO) Fits Minervini's Trend Template with Strong Technicals and Earnings Momentum
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Offers Affordable Growth With Strong Fundamentals
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out in Navellier's Growth Screen
Via Chartmill
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
Via Investor's Business Daily
Topics ETFs
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out as a Top Undervalued Stock with Strong Fundamentals
Via Chartmill
What 7 Analyst Ratings Have To Say About Halozyme Therapeutics
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Top Pick for Affordable Growth Investors
Via Chartmill
What Does the Market Think About Halozyme Therapeutics?
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Fits Louis Navellier’s High-Growth Stock Criteria
Via Chartmill
Halozyme (HALO) Q2 EPS Jumps 69%
Via The Motley Fool
Topics Intellectual Property
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Shows Strong Growth Momentum and Technical Breakout Potential
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Stands Out as a Strong Undervalued Stock with Solid Fundamentals
Via Chartmill
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Contender in Affordable Growth Stocks
Via Chartmill
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Candidate for Affordable Growth Investors
Via Chartmill

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 64.54
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/09/25 02:21 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.19B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.